IMMUNE AND MOLECULAR CORRELATES OF RESPONSE TO IMMUNOTHERAPY REVEALED BY BRAIN-METASTATIC MELANOMA MODELS
Preprint
Abstract
SUMMARY: Despite the promising results of immune checkpoint blockade (ICB) therapy, outcomes for patients with brain metastasis (BrM) remain poor. Identifying resistance mechanisms has been hindered by limited access to patient samples and relevant preclinical models. Here, we developed two mouse melanoma BrM models that recapitulate the disparate responses to ICB seen in patients. We demonstrate that these models capture the cellular and molecular complexity of human disease and reveal key factors shaping the tumor microenvironment and influencing ICB response. BR1-responsive tumor cells express inflammatory programs that polarize microglia into reactive states, eliciting robust T cell recruitment. In contrast, BR3-resistant melanoma cells are enriched in neurological programs and exploit tolerance mechanisms to maintain microglia homeostasis and limit T cell infiltration. In humans, BR1 and BR3 expression signatures correlate positively or negatively with T cell infiltration and BrM patient outcomes, respectively. Our study provides clinically relevant models and uncovers mechanistic insights into BrM ICB responses, offering potential biomarkers and therapeutic targets to improve therapy efficacy.Keywords
This publication has 135 references indexed in Scilit:
- Immune checkpoint inhibitor treatment of brain metastasis associated with a less invasive growth pattern, higher T-cell infiltration and raised tumor ADC on diffusion weighted MRICancer Immunology, Immunotherapy, 2023
- Gas6 Promotes Microglia Efferocytosis and Suppresses Inflammation Through Activating Axl/Rac1 Signaling in Subarachnoid Hemorrhage MiceTranslational Stroke Research, 2022
- A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancersCancer Cell, 2022
- Arginase: An emerging and promising therapeutic target for cancer treatmentBiomedicine & Pharmacotherapy, 2022
- Integration, exploration, and analysis of high‐dimensional single‐cell cytometry data using SpectreCytometry Part A, 2021
- Melanoma brain metastasis presentation, treatment, and outcomes in the age of targeted and immunotherapiesCancer, 2021
- Characterization of the tumor immune infiltrate by multiparametric flow cytometry and unbiased high-dimensional data analysis2019
- The Microenvironmental Landscape of Brain TumorsCancer Cell, 2017
- Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC)Journal of Neuro-Oncology, 2016
- Therapeutic potential of Galectin‐9 in human diseaseMedicinal Research Reviews, 2011